Jaguar Health (JAGX) Net Cash Flow (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Net Cash Flow data on file, last reported at $2.2 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $2.2 million, up 194.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (up 176.43% YoY), and the FY2025 annual result was -$57000.0, down 103.59% from the prior year.
• Net Cash Flow slipped to $2.2 million in Q1 2026 per JAGX's latest filing, from $4.3 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $8.9 million in Q1 2023 and troughed at -$7.2 million in Q2 2022.
• A 5-year average of -$325882.4 and a median of $455000.0 in 2022 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow sank 2071.99% in 2022, then soared 1848.57% in 2023.
• A 5-year view of Net Cash Flow shows it stood at -$5.1 million in 2022, then jumped by 162.16% to $3.2 million in 2023, then plunged by 262.89% to -$5.2 million in 2024, then soared by 182.81% to $4.3 million in 2025, then tumbled by 48.67% to $2.2 million in 2026.
• Business Quant data shows JAGX's Net Cash Flow at $2.2 million in Q1 2026, $4.3 million in Q4 2025, and $1.6 million in Q3 2025.